Stock News | Market Tamer Stock and Options Training

Stryker (NYSE: SYK) and Medtronic (NYSE: MDT) are a pair of the biggest and most important medical-device and supply companies out there, but they're a bit different in the stability of the dividend income they offer to investors. Overall, Stryker's business is quite stable: It makes medical equipment, medical instruments, and surgical robotics for healthcare systems worldwide, and there isn't much in the way of rapidly shifting demand for its major segments. But it can reliably generate growth by investing in research and development (R&D) to make incremental improvements to its existing products, even if that growth is unlikely to be rapid due to the slow-growing nature of its markets. For example, developing more-advanced hip replacement products for use with its surgical robot system probably won't make investors rich overnight, but it'll keep the top and bottom lines expanding.

Stryker declares a $0.75 per share quarterly dividend

Zacks Industry Outlook Highlights Stryker, Boston Scientific, Zimmer Biomet and Insulet

4 Medical Products Stocks to Capitalize on the Industry's Recovery

Medical Device Maker Stryker Faces New Bribery Concerns

Got $5,000? Buy These 2 Stalwart Stocks and Hold Them Forever

What's Going On With Stryker Stock Today

BAX vs. SYK: Which Stock Should Value Investors Buy Now?

Stryker completes acquisition of Cerus Endovascular

Stryker (SYK) Q1 Earnings Beat Estimates, Volume Improves

Stryker (SYK) Tops Q1 Earnings and Revenue Estimates

Stryker lifts profit forecast on robust demand for devices

Stryker reports first quarter 2023 operating results

3 Medical Device Stocks Outpacing the Healthcare Industry This Year